fashion -WSS

fashion

author：Wikipedia 2025-10-01 10:35:27 - browse：5151

a liver made up by geometric shapes – biotech coverage from STAT — Adobe

LONDON — A drug in development as a weight loss treatment succeeded in a Phase 2 study in a serious liver condition, its developers said Monday, as the competition in the broader obesity medicine field pushes ahead.

The drug, survodutide, is being developed by the privately held German firm Boehringer Ingelheim and the Danish biotech Zealand Pharma. Zealand’s share price has doubled over the past year over the potential of the drug, and on Monday morning, shares jumped another 25%.

In the study, 83% of patients with a condition called MASH and who were treated with survodutide saw significant improvements in their disease compared to 18% of those who received placebo. The study met its primary endpoint of improvements in MASH after 48 weeks without the worsening of fibrosis, a scarring of the liver, the companies said. Secondary endpoints were also met, including an improvement in fibrosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Teladoc has a new CEO, but challenges remain the same

WSS

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

New report analyzes digital physical therapy solutions' effectiveness

At ASCO, AstraZeneca reports strong data for breast cancer drug

Let's speed up science by embracing open access publishing

NIH tests clinical research in primary care with $30 million program

My daughter's legacy lives on through her writing, phage therapy

Wikipedia

fashion

explore

Guidelines to prevent youth baseball injuries need more muscle

Cigna wins case to block Amy Bricker's move to CVS

How to save PrEP access — and even expand it

Change Healthcare can notify patients about the breach, HHS says

Activists slam private health insurers over coverage restrictions

Innovation in antibiotics is ailing. 'Brain drain' may kill it

Hollywood unions extend contract negotiations for actors

Coercive sterilizations revealed by STAT prompt outrage

George Santos makes 1st court appearance after pleading not guilty to 13 counts

FDA's Pazdur wants cancer trials to range beyond China alone

knowledge

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

Teladoc has a new CEO, but challenges remain the same

See how much Covid

STAT Virtual Event: ASCO Recap, Live!

Ionis drug prevents swelling attacks due to hereditary angioedema

New report analyzes digital physical therapy solutions' effectiveness

hotspot

focus

Wikipedia

hotspot